Atlas Diagnostics ATDX
team's prior 12 calls
Coincident speaker deviation
Both the CEO and CFO deviate above 2σ on this call. In our corpus, this co-occurrence happens in roughly 1.8% of management-team-quarters. Single-executive deviation is common — coincident deviation is rare and historically informative.
What this pattern has meant historically
Speaker decomposition
How we score paragraphs and phrases
| Axis 1 | Exact phrase — verbatim-novel vs this speaker's 12 prior calls |
| Axis 2 | Loaded keyword — elevated hedge/qualifier density |
| Axis 3 | Semantic phrase — below the 0.85 cosine precedent threshold |
| Axis 4 | Concept novelty — a topic the speaker hasn't framed this way before |
| Axis 5 | Boilerplate Drift — descriptor slot drift in recurring boilerplate |
Paragraph scores weight those flags by topic (forward-guidance counts more than past-results recap) and by length-normalized hedge density. Baselines are per speaker, not company-level — a new CFO builds baseline over their first few quarters.
Annotated prepared remarks
Thanks, James. Good morning, everyone, and thanks for joining us today for our first quarter call. As you saw in our press release, we delivered another quarter of solid financial performance.
At the beginning of the year, we set out appropriately ambitious guidance for the year and we are reaffirming our outlook today. Our team continues to maintain our ambitious full year outlook despite the fact that the macro environment has become slightly more challenging.
We've seen evolving demand signals across our diagnostics segment, particularly in the back half. If conditions warrant, we will appropriately adjust guidance over time, while continuing to focus on the levers we control.
With that, I'll turn it over to Sarah to walk through the financial details. Sarah?
Thanks, David. Beginning with our full-year guidance. We are reaffirming our prior guidance of revenue between $4.2 billion and $4.3 billion, and adjusted EPS of $2.85. Our guidance reflects no net change overall from the guidance we shared at our Q4 call, with our key underlying assumptions that remain unchanged.
We are currently assuming Q2 revenue will be slightly lower than Q1 due to a higher weighting of revenue and adjusted EPS in the second half of the year. We expect to achieve our full-year guidance through performance that may be different from the way we planned the year.
Turning to segment performance. Diagnostics revenue grew 4% in the quarter, in line with our expectations. Instruments was up 6%, and consumables grew at low single digits, reflecting ongoing normalization of customer ordering patterns following last year's pull-forward.
With that, we're happy to take your questions. Operator?
Q&A · scored by exchange
3 of 8 exchanges shownBoilerplate Drift
“we delivered another quarter of excellent financial performance”
“we delivered another quarter of very strong financial performance”
“we delivered another quarter of solid financial performance”
Q1 guidance posture · 4-year trajectory
Run this on your watchlist.
Spoken Alpha tracks behavioral baselines across 12,408 speakersat S&P 1500 companies. Search any earnings call, surface verbatim-novel language, and see how this management team has drifted from itself.